skip to main content
Language:
Search Limited to: Search Limited to: Resource type Show Results with: Show Results with: Search type Index

Results 1 - 20 of 3,493  for All Library Resources

Sorted by: Sorted by: RelevanceOr hit Enter to replace sort method
Results 1 2 3 4 5 next page
Refined by: Database: Open Access Journals remove language: English remove
Result Number Material Type Add to My Shelf Action Record Details and Options
1
28 APS antibodies: managing patients when laboratory scenarios don’t fit guidelines
28 APS antibodies: managing patients when laboratory scenarios don’t fit guidelines
Material Type:
Article 		Add to My Research

28 APS antibodies: managing patients when laboratory scenarios don’t fit guidelines

Lupus science & medicine, 2022-04, Vol.9 (Suppl 1), p.A15-A16 [Peer Reviewed Journal]

Author(s) (or their employer(s)) 2022. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. ;2022 Author(s) (or their employer(s)) 2022. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. http://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;EISSN: 2053-8790 ;DOI: 10.1136/lupus-2022-la.28

Full text available

Citations Cited by
2
I39 Management of refractory APS
I39 Management of refractory APS
Material Type:
Article 		Add to My Research

I39 Management of refractory APS

Lupus science & medicine, 2024-03, Vol.11 (Suppl 1), p.A4-A4 [Peer Reviewed Journal]

Author(s) (or their employer(s)) 2022. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. ;2022 Author(s) (or their employer(s)) 2022. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. http://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;EISSN: 2053-8790 ;DOI: 10.1136/lupus-2024-el.7

Full text available

Citations Cited by
3
LO-041 Severe thrombocytopenia is associated with adverse pregnancy outcomes in obstetric antiphospholipid syndrome
LO-041 Severe thrombocytopenia is associated with adverse pregnancy outcomes in obstetric antiphospholipid syndrome
Material Type:
Article 		Add to My Research

LO-041 Severe thrombocytopenia is associated with adverse pregnancy outcomes in obstetric antiphospholipid syndrome

Lupus science & medicine, 2023-07, Vol.10 (Suppl 1), p.A34-A34 [Peer Reviewed Journal]

2023 Author(s) (or their employer(s)) 2023. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. http://creativecommons.org/licenses/by-nc/4.0/ This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ . Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;EISSN: 2053-8790 ;DOI: 10.1136/lupus-2023-KCR.42

Full text available

Citations Cited by
4
Risk of ovarian cancer in mothers after assisted reproductive therapy (ART) - a registry-based cohort study from the Committee of Nordic ART and Safety
Risk of ovarian cancer in mothers after assisted reproductive therapy (ART) - a registry-based cohort study from the Committee of Nordic ART and Safety
Material Type:
Article 		Add to My Research

Risk of ovarian cancer in mothers after assisted reproductive therapy (ART) - a registry-based cohort study from the Committee of Nordic ART and Safety

British journal of cancer, 2022, Vol.Accepted [Peer Reviewed Journal]

ISSN: 0007-0920 ;ISSN: 1532-1827 ;EISSN: 1532-1827

Full text available

Citations Cited by
5
P5 Patients with obstetric antiphospholipid syndrome have constitutively higher complement activation compared to healthy controls
P5 Patients with obstetric antiphospholipid syndrome have constitutively higher complement activation compared to healthy controls
Material Type:
Article 		Add to My Research

P5 Patients with obstetric antiphospholipid syndrome have constitutively higher complement activation compared to healthy controls

Lupus science & medicine, 2024-03, Vol.11 (Suppl 1), p.A45-A46 [Peer Reviewed Journal]

Author(s) (or their employer(s)) 2022. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. ;2022 Author(s) (or their employer(s)) 2022. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. http://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;EISSN: 2053-8790 ;DOI: 10.1136/lupus-2024-el.59

Full text available

Citations Cited by
6
P1 Intra-renal involvement in primary antiphospholipid antibodies syndrome: data from two Italian centers
P1 Intra-renal involvement in primary antiphospholipid antibodies syndrome: data from two Italian centers
Material Type:
Article 		Add to My Research

P1 Intra-renal involvement in primary antiphospholipid antibodies syndrome: data from two Italian centers

Lupus science & medicine, 2024-03, Vol.11 (Suppl 1), p.A42-A43 [Peer Reviewed Journal]

Author(s) (or their employer(s)) 2022. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. ;2022 Author(s) (or their employer(s)) 2022. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. http://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;EISSN: 2053-8790 ;DOI: 10.1136/lupus-2024-el.55

Full text available

Citations Cited by
7
The benefits and harms of breast cancer screening: an independent review
The benefits and harms of breast cancer screening: an independent review
Material Type:
Article 		Add to My Research

The benefits and harms of breast cancer screening: an independent review

British journal of cancer, 2013-06, Vol.108 (11), p.2205-2240 [Peer Reviewed Journal]

2014 INIST-CNRS ;Copyright Nature Publishing Group Jun 11, 2013 ;ISSN: 0007-0920 ;EISSN: 1532-1827 ;DOI: 10.1038/bjc.2013.177 ;PMID: 23744281 ;CODEN: BJCAAI

Full text available

Citations Cited by
8
Neurosurgical emergencies during pregnancy – Management dilemmas
Neurosurgical emergencies during pregnancy – Management dilemmas
Material Type:
Article 		Add to My Research

Neurosurgical emergencies during pregnancy – Management dilemmas

Surgical neurology international, 2023-04, Vol.14, p.151, Article 151

Copyright: © 2023 Surgical Neurology International 2023 ;ISSN: 2229-5097 ;EISSN: 2152-7806 ;DOI: 10.25259/SNI_1076_2022

Full text available

Citations Cited by
9
Cancer-associated fibroblasts induce epithelial―mesenchymal transition of breast cancer cells through paracrine TGF-β signalling
Cancer-associated fibroblasts induce epithelial―mesenchymal transition of breast cancer cells through paracrine TGF-β signalling
Material Type:
Article 		Add to My Research

Cancer-associated fibroblasts induce epithelial―mesenchymal transition of breast cancer cells through paracrine TGF-β signalling

British journal of cancer, 2014-02, Vol.110 (3), p.724-732 [Peer Reviewed Journal]

2015 INIST-CNRS ;Copyright © 2014 Cancer Research UK 2014 Cancer Research UK ;ISSN: 0007-0920 ;EISSN: 1532-1827 ;DOI: 10.1038/bjc.2013.768 ;PMID: 24335925 ;CODEN: BJCAAI

Full text available

Citations Cited by
10
Risk and prognosis of ovarian cancer in women with endometriosis: a meta-analysis
Risk and prognosis of ovarian cancer in women with endometriosis: a meta-analysis
Material Type:
Article 		Add to My Research

Risk and prognosis of ovarian cancer in women with endometriosis: a meta-analysis

British journal of cancer, 2014-04, Vol.110 (7), p.1878-1890 [Peer Reviewed Journal]

2015 INIST-CNRS ;Copyright Nature Publishing Group Apr 1, 2014 ;Copyright © 2014 Cancer Research UK 2014 Cancer Research UK ;ISSN: 0007-0920 ;EISSN: 1532-1827 ;DOI: 10.1038/bjc.2014.29 ;PMID: 24518590 ;CODEN: BJCAAI

Full text available

Citations Cited by
11
An Analysis of the Number of Patients Screened, Approached and Enrolled in Randomized Controlled Trials
An Analysis of the Number of Patients Screened, Approached and Enrolled in Randomized Controlled Trials
Material Type:
Article 		Add to My Research

An Analysis of the Number of Patients Screened, Approached and Enrolled in Randomized Controlled Trials

Medicine and health, Rhode Island, 2024-02, Vol.107 (2), p.48-49 [Peer Reviewed Journal]

Copyright Rhode Island Medical Society Feb 2024 ;EISSN: 2163-5730

Digital Resources/Online E-Resources

Citations Cited by
12
Patterns of genomic loss of heterozygosity predict homologous recombination repair defects in epithelial ovarian cancer
Patterns of genomic loss of heterozygosity predict homologous recombination repair defects in epithelial ovarian cancer
Material Type:
Article 		Add to My Research

Patterns of genomic loss of heterozygosity predict homologous recombination repair defects in epithelial ovarian cancer

British journal of cancer, 2012-11, Vol.107 (10), p.1776-1782 [Peer Reviewed Journal]

2015 INIST-CNRS ;Copyright Nature Publishing Group Nov 6, 2012 ;Copyright © 2012 Cancer Research UK 2012 Cancer Research UK ;ISSN: 0007-0920 ;EISSN: 1532-1827 ;DOI: 10.1038/bjc.2012.451 ;PMID: 23047548 ;CODEN: BJCAAI

Full text available

Citations Cited by
13
Looking for Meaning in Labour Pain: Are Current Pain Measurement Tools Adequate?
Looking for Meaning in Labour Pain: Are Current Pain Measurement Tools Adequate?
Material Type:
Article 		Add to My Research

Looking for Meaning in Labour Pain: Are Current Pain Measurement Tools Adequate?

Pain medicine (Malden, Mass.), 2021-05, Vol.22 (5), p.1023-1028 [Peer Reviewed Journal]

The Author(s) 2020. Published by Oxford University Press on behalf of the American Academy of Pain Medicine. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com 2020 ;COPYRIGHT 2021 Oxford University Press ;The Author(s) 2020. Published by Oxford University Press on behalf of the American Academy of Pain Medicine. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com ;ISSN: 1526-2375 ;EISSN: 1526-4637 ;DOI: 10.1093/pm/pnaa380

Full text available

Citations Cited by
14
Spanish Mediterranean diet and other dietary patterns and breast cancer risk: case-control EpiGEICAM study
Spanish Mediterranean diet and other dietary patterns and breast cancer risk: case-control EpiGEICAM study
Material Type:
Article 		Add to My Research

Spanish Mediterranean diet and other dietary patterns and breast cancer risk: case-control EpiGEICAM study

British journal of cancer, 2014-09, Vol.111 (7), p.1454-1462 [Peer Reviewed Journal]

2015 INIST-CNRS ;Copyright Nature Publishing Group Sep 23, 2014 ;Copyright © 2014 Cancer Research UK 2014 Cancer Research UK ;ISSN: 0007-0920 ;EISSN: 1532-1827 ;DOI: 10.1038/bjc.2014.434 ;PMID: 25101568 ;CODEN: BJCAAI

Full text available

Citations Cited by
15
Tumour-infiltrating FOXP3+ lymphocytes are associated with cytotoxic immune responses and good clinical outcome in oestrogen receptor-negative breast cancer
Tumour-infiltrating FOXP3+ lymphocytes are associated with cytotoxic immune responses and good clinical outcome in oestrogen receptor-negative breast cancer
Material Type:
Article 		Add to My Research

Tumour-infiltrating FOXP3+ lymphocytes are associated with cytotoxic immune responses and good clinical outcome in oestrogen receptor-negative breast cancer

British journal of cancer, 2013-01, Vol.108 (1), p.155-162 [Peer Reviewed Journal]

2014 INIST-CNRS ;Copyright Nature Publishing Group Jan 15, 2013 ;Copyright © 2013 Cancer Research UK 2013 Cancer Research UK ;ISSN: 0007-0920 ;EISSN: 1532-1827 ;DOI: 10.1038/bjc.2012.524 ;PMID: 23169287 ;CODEN: BJCAAI

Full text available

Citations Cited by
16
Eribulin mesilate suppresses experimental metastasis of breast cancer cells by reversing phenotype from epithelial―mesenchymal transition (EMT) to mesenchymal―epithelial transition (MET) states
Eribulin mesilate suppresses experimental metastasis of breast cancer cells by reversing phenotype from epithelial―mesenchymal transition (EMT) to mesenchymal―epithelial transition (MET) states
Material Type:
Article 		Add to My Research

Eribulin mesilate suppresses experimental metastasis of breast cancer cells by reversing phenotype from epithelial―mesenchymal transition (EMT) to mesenchymal―epithelial transition (MET) states

British journal of cancer, 2014-03, Vol.110 (6), p.1497-1505 [Peer Reviewed Journal]

2015 INIST-CNRS ;Copyright Nature Publishing Group Mar 18, 2014 ;Copyright © 2014 Cancer Research UK 2014 Cancer Research UK ;ISSN: 0007-0920 ;EISSN: 1532-1827 ;DOI: 10.1038/bjc.2014.80 ;PMID: 24569463 ;CODEN: BJCAAI

Full text available

Citations Cited by
17
Cohort study of adherence to adjuvant endocrine therapy, breast cancer recurrence and mortality
Cohort study of adherence to adjuvant endocrine therapy, breast cancer recurrence and mortality
Material Type:
Article 		Add to My Research

Cohort study of adherence to adjuvant endocrine therapy, breast cancer recurrence and mortality

British journal of cancer, 2013-04, Vol.108 (7), p.1515-1524 [Peer Reviewed Journal]

2014 INIST-CNRS ;Copyright Nature Publishing Group Apr 16, 2013 ;Copyright © 2013 Cancer Research UK 2013 Cancer Research UK ;ISSN: 0007-0920 ;EISSN: 1532-1827 ;DOI: 10.1038/bjc.2013.116 ;PMID: 23519057 ;CODEN: BJCAAI

Full text available

Citations Cited by
18
Tumour-infiltrating CD8 + lymphocytes as an independent predictive factor for pathological complete response to primary systemic therapy in breast cancer
Tumour-infiltrating CD8 + lymphocytes as an independent predictive factor for pathological complete response to primary systemic therapy in breast cancer
Material Type:
Article 		Add to My Research

Tumour-infiltrating CD8 + lymphocytes as an independent predictive factor for pathological complete response to primary systemic therapy in breast cancer

British journal of cancer, 2013-11, Vol.109 (10), p.2705-2713 [Peer Reviewed Journal]

2015 INIST-CNRS ;Copyright Nature Publishing Group Nov 12, 2013 ;Copyright © 2013 Cancer Research UK 2013 Cancer Research UK ;ISSN: 0007-0920 ;EISSN: 1532-1827 ;DOI: 10.1038/bjc.2013.634 ;PMID: 24129232 ;CODEN: BJCAAI

Full text available

Citations Cited by
19
A direct comparison of CellSearch and ISET for circulating tumour-cell detection in patients with metastatic carcinomas
A direct comparison of CellSearch and ISET for circulating tumour-cell detection in patients with metastatic carcinomas
Material Type:
Article 		Add to My Research

A direct comparison of CellSearch and ISET for circulating tumour-cell detection in patients with metastatic carcinomas

British journal of cancer, 2011-09, Vol.105 (6), p.847-853 [Peer Reviewed Journal]

2015 INIST-CNRS ;Copyright Nature Publishing Group Sep 6, 2011 ;Copyright © 2011 Cancer Research UK 2011 Cancer Research UK ;ISSN: 0007-0920 ;EISSN: 1532-1827 ;DOI: 10.1038/bjc.2011.294 ;PMID: 21829190 ;CODEN: BJCAAI

Full text available

Citations Cited by
20
Intragenic DNA methylation: implications of this epigenetic mechanism for cancer research
Intragenic DNA methylation: implications of this epigenetic mechanism for cancer research
Material Type:
Article 		Add to My Research

Intragenic DNA methylation: implications of this epigenetic mechanism for cancer research

British journal of cancer, 2012-01, Vol.106 (2), p.248-253 [Peer Reviewed Journal]

2015 INIST-CNRS ;Copyright Nature Publishing Group Jan 17, 2012 ;Copyright © 2012 Cancer Research UK 2012 Cancer Research UK ;ISSN: 0007-0920 ;EISSN: 1532-1827 ;DOI: 10.1038/bjc.2011.550 ;PMID: 22166804 ;CODEN: BJCAAI

Full text available

Citations Cited by

Results 1 - 20 of 3,493  for All Library Resources

Sorted by: Sorted by: RelevanceOr hit Enter to replace sort method
Results 1 2 3 4 5 next page

Personalize your results

  1. Edit

Refine Search Results

Expand My Results

  1.   

Refine My Results

Creation Date 

From To
Refine
  1. Before 1987  (129)
  2. 1987 To 1995  (649)
  3. 1996 To 2004  (1,145)
  4. 2005 To 2014  (1,373)
  5. After 2014  (197)
  6. More options open sub menu

Resource Type 

  1. Articles  (3,285)
  2. magazinearticle  (122)
  3. Newspaper Articles  (47)
  4. Reviews  (39)
  5. More options open sub menu

Language 

  1. Japanese  (504)
  2. Portuguese  (2)
  3. Spanish  (1)
  4. More options open sub menu
INSPIRE LIBRARY - TON DUC THANG UNIVERSITY (84-028) 37 755 057 Feedback
19 Nguyen Huu Tho St. Dist.7, HCM thuvien@tdtu.edu.vn

Copyright © 2017 INSPIRE LIBRARY - TON DUC THANG UNIVERSITY

Searching Remote Databases, Please Wait